FMP

FMP

Enter

XAIR - Beyond Air, Inc.

Financial Summary of Beyond Air, Inc.(XAIR), Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company

photo-url-https://financialmodelingprep.com/image-stock/XAIR.png

Beyond Air, Inc.

XAIR

NASDAQ

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

1.19 USD

-0.09 (-7.56%)

About

ceo

Mr. Steven Adam Lisi

sector

Healthcare

industry

Medical - Devices

website

https://www.beyondair.net

exchange

NASDAQ

Description

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden...

CIK

0001641631

ISIN

US08862L1035

CUSIP

08862L103

Address

900 Stewart Avenue

Phone

516 665 8200

Country

US

Employee

98

IPO Date

Jun 12, 2018

Summary

CIK

0001641631

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

08862L103

ISIN

US08862L1035

Country

US

Price

1.19

Beta

-0.19

Volume Avg.

297.13k

Market Cap

54.62M

Shares

-

52-Week

1.139-6.36

DCF

0.85

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.56

P/B

-

Website

https://www.beyondair.net

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest XAIR News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep